- Home
- CHNR vs LSBPW Comparison
CHNR vs LSBPW Comparison
Compare CHNR & LSBPW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CHNR
- LSBPW
- Stock Information
- Founded
- CHNR N/A
- LSBPW N/A
- Country
- CHNR Hong Kong
- LSBPW China
- Employees
- CHNR N/A
- LSBPW 758
- Industry
- CHNR Precious Metals
- LSBPW Biotechnology: Pharmaceutical Preparations
- Sector
- CHNR Basic Materials
- LSBPW Health Care
- Exchange
- CHNR Nasdaq
- LSBPW Nasdaq
- Market Cap
- CHNR 6.4M
- LSBPW N/A
- IPO Year
- CHNR 1995
- LSBPW N/A
- Fundamental
- Price
- CHNR $0.79
- LSBPW $0.07
- Analyst Decision
- CHNR
- LSBPW
- Analyst Count
- CHNR 0
- LSBPW 0
- Target Price
- CHNR N/A
- LSBPW N/A
- AVG Volume (30 Days)
- CHNR 148.0K
- LSBPW N/A
- Earning Date
- CHNR 01-01-0001
- LSBPW N/A
- Dividend Yield
- CHNR N/A
- LSBPW N/A
- EPS Growth
- CHNR N/A
- LSBPW N/A
- EPS
- CHNR N/A
- LSBPW N/A
- Revenue
- CHNR N/A
- LSBPW N/A
- Revenue This Year
- CHNR N/A
- LSBPW N/A
- Revenue Next Year
- CHNR N/A
- LSBPW N/A
- P/E Ratio
- CHNR N/A
- LSBPW N/A
- Revenue Growth
- CHNR N/A
- LSBPW N/A
- 52 Week Low
- CHNR $0.55
- LSBPW N/A
- 52 Week High
- CHNR $8.85
- LSBPW N/A
- Technical
- Relative Strength Index (RSI)
- CHNR 53.35
- LSBPW N/A
- Support Level
- CHNR $0.68
- LSBPW N/A
- Resistance Level
- CHNR $0.83
- LSBPW N/A
- Average True Range (ATR)
- CHNR 0.10
- LSBPW 0.00
- MACD
- CHNR -0.00
- LSBPW 0.00
- Stochastic Oscillator
- CHNR 24.60
- LSBPW 0.00
About CHNR China Natural Resources Inc.
China Natural Resources Inc is an investment holding company. It principally engaged in the exploration and mining and wastewater treatment businesses in the People's Republic of China. The company has two operating segments: (i) Wastewater treatment segment, which consists of sales of assembled equipment, provision of construction service, and participation in PPP projects as an operator (ii) Exploration and mining segment, which consists of the exploration of lead, silver, and other metals in the Inner Mongolia Autonomous Region of the PRC and the trading of copper ores products. It earns the majority of its revenue from the Wastewater treatment segment.
About LSBPW LakeShore Biopharma Co. Ltd
LakeShore Biopharma Co Ltd is a biopharmaceutical company dedicated to discovering, developing, manufacturing, and delivering new generations of vaccines and therapeutic biologics for infectious diseases and cancer. It has developed a proprietary PIKA immunomodulating technology platform and a new generation of preventive and therapeutic biologics targeting Rabies, Coronavirus, Hepatitis B, Influenza, Shingles, and other virus infections. The company operates in China, the United States, Singapore, and the Philippines.